Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nehal Elfar"'
Autor:
Mohamed Yasser, Eman E. El Naggar, Nehal Elfar, Mahmoud H. Teaima, Mohamed A. El-Nabarawi, Sammar Fathy Elhabal
Publikováno v:
International Journal of Pharmaceutics: X, Vol 7, Iss , Pp 100228- (2024)
The study aims to improve the ocular delivery of Nebivolol HCL (NBV) belonging to the Biopharmaceutics classification system (BCSII) by using spanlastic nanovesicles (SNVs) for ophthalmic delivery and incorporating them into hydroxypropyl methylcellu
Externí odkaz:
https://doaj.org/article/ead3b3968afe4466b17c82839855893f
Autor:
Sammar Fathy Elhabal, Mohamed A El-Nabarawi, Nashwa Abdelaal, Mohamed Fathi Mohamed Elrefai, Shrouk A. Ghaffar, Mohamed Mansour Khalifa, Passant M. Mohie, Dania S. Waggas, Ahmed Mohsen Elsaid Hamdan, Samar Zuhair Alshawwa, Essa M. Saied, Nahla A. Elzohairy, Tayseer Elnawawy, Rania A. Gad, Nehal Elfar, Hanaa Mohammed, Mohammad Ahmad Khasawneh
Publikováno v:
Drug Delivery, Vol 30, Iss 1 (2023)
AbstractCanagliflozin (CFZ) is a sodium-glucose cotransporter-2 inhibitor (SGLT2) that lowers albuminuria in type-2 diabetic patients, cardiovascular, kidney, and liver disease. CFZ is classified as class IV in the Biopharmaceutical Classification Sy
Externí odkaz:
https://doaj.org/article/a2cf42c96704498086c5780200e30e93
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0266019 (2022)
BackgroundDisturbed sleep can cause to m health problems such as cognitive impairment, depressed mood, and negative effects on cardiovascular, endocrine, and immune function. This study formulates and optimizes Eszopiclone trilaminate fast dissolving
Externí odkaz:
https://doaj.org/article/e8e6bcbe892c4489aa2dd934b1054349
Publikováno v:
PloS one. 17(6)
Background Disturbed sleep can cause to m health problems such as cognitive impairment, depressed mood, and negative effects on cardiovascular, endocrine, and immune function. This study formulates and optimizes Eszopiclone trilaminate fast dissolvin
Autor:
Fathy Elhabal, Sammar1 (AUTHOR) Sammar.Fathy@pharm.mti.edu.eg, El-Nabarawi, Mohamed A2 (AUTHOR), Abdelaal, Nashwa3 (AUTHOR), Elrefai, Mohamed Fathi Mohamed4,5 (AUTHOR), Ghaffar, Shrouk A.6 (AUTHOR), Khalifa, Mohamed Mansour7,8 (AUTHOR), Mohie, Passant M.9 (AUTHOR), Waggas, Dania S.10 (AUTHOR), Hamdan, Ahmed Mohsen Elsaid11 (AUTHOR), Alshawwa, Samar Zuhair12 (AUTHOR), Saied, Essa M.13,14 (AUTHOR), Elzohairy, Nahla A.15,16 (AUTHOR), Elnawawy, Tayseer17 (AUTHOR), Gad, Rania A.18 (AUTHOR), Elfar, Nehal19 (AUTHOR), Mohammed, Hanaa20 (AUTHOR), Khasawneh, Mohammad Ahmad21 (AUTHOR) mohammad.khasawneh@uaeu.ac.ae
Publikováno v:
Drug Delivery. Dec2023, Vol. 30 Issue 1, p1-16. 16p.
Autor:
Teaima, Mahmoud1 (AUTHOR) mahmoud.teaima@pharma.cu.edu.eg, Yasser, Mohamed2 (AUTHOR), Elfar, Nehal2 (AUTHOR), Shoueir, Kamel3 (AUTHOR), El-Nabarawi, Mohamed1 (AUTHOR), Helal, Doaa4 (AUTHOR)
Publikováno v:
PLoS ONE. 6/9/2022, Vol. 17 Issue 6, p1-13. 13p.
Autor:
Elhabal, Sammar Fathy, Abdelaal, Nashwa, Al-Zuhairy, Saeed AS, Elrefai, Mohamed Fathi Mohamed, Khalifa, Mohamed Mansour, Khasawneh, Mohammad Ahmad, Hamdan, Ahmed Mohsen Elsaid, Mohie, Passant M, Gad, Rania A, Kabil, Soad L, El-Ashery, Mohamed Kandeel, Jasti, Bhaskara R, Elzohairy, Nahla A, Elfar, Nehal, Elnawawy, Tayseer, Hassan, Fatma E, El-Nabarawi, Mohamed Ahmed
Publikováno v:
International Journal of Nanomedicine; Feb2024, Vol. 19, p1163-1187, 25p